Vicki S. Freeman

Impact of time lapse on ASCP board of certification medical laboratory scientist (MLS) and medical laboratory technician (MLT) examination scores

BACKGROUND Research in several professional fields has demonstrated that delays (time lapse) in taking certification examinations may result in poorer performance by examinees. Thirteen states and/or territories require licensure for laboratory personnel. A core component of licensure is passing a certification exam. Also, many facilities in states that do not require licensure require certification for employment or preferentially hire certified individuals. OBJECTIVE To analyze examinee performance on the American Society for Clinical Pathology (ASCP) Board of Certification (BOC) Medical Laboratory Scientist (MLS) and Medical Laboratory Technician (MLT) certification examinations to determine whether delays in taking the examination from the time of program completion are associated with poorer performance. METHODS We obtained examination data from April 2013 through December 2014 to look for changes in mean (SD) exam scaled scores and overall pass/fail rates. First-time examinees (MLS: n = 6037; MLT, n = 3920) were divided into 3-month categories based on the interval of time between date of program completion and taking the certification exam. RESULTS We observed significant decreases in mean (SD) scaled scores and pass rates after the first quarter in MLS and MLT examinations for applicants who delayed taking their examination until the second, third, and fourth quarter after completing their training programs. CONCLUSIONS Those who take the ASCP BOC MLS and MLT examinations are encouraged to do so shortly after completion of their educational training programs. Delays in taking an exam are generally not beneficial to the examinee and result in poorer performance on the exam.

Glucose and Hemoglobin A1c

Glucose, a monosaccharide, is the primary source of energy for the human body. It is used by the liver and other cells for energy or stored as glycogen for later use. The level of glucose in the bloodstream is regulated by 2 pancreatic hormones, insulin and glucagon. Insulin is released when glucose levels rise. Insulin acts by increasing glycogenesis, lipogenesis, and glycolysis, causing a decrease of glucose in the bloodstream. Glucagon is released when glucose levels fall, causing the liver to release stored glucose (glycogen) into the bloodstream (glycogenolysis), thereby increasing the level of glucose in the bloodstream. Hemoglobin A1c (HbA1c), also called glycosylated hemoglobin, is a hemoglobin compound produced when glucose reacts with the amino group on a hemoglobin molecule forming a ketoamine. The glucose molecule is attached to one or both N-terminal valines of the β-polypeptide chains of normal adult hemoglobin.1 The HbA1c formation is proportional to the blood glucose concentrations. Because the average red blood cell life is approximately 120 days, the glycosylated hemoglobin level reflects the average blood glucose level during the previous 2 to 3 months. Glucose testing is used to determine if an individual has hyperglycemia or hypoglycemia. A high fasting glucose level (≥126 mg/dL) and/or a high HbA1c level (>6.5%) might indicate that an individual has diabetes mellitus. HbA1c is a reliable method of monitoring long-term diabetes mellitus control; it determines the average blood glucose level of an individual during a period of approximately 3 months. Normal values range from 4.0% to 6.0%. Results of a study2 have shown the strong linear relationship between average blood glucose levels and HbA1c levels. Current American Diabetes mellitus Association guidelines recommend that a HbA1c test be performed at least twice yearly on patients who are meeting treatment … [↵][1]* To whom correspondence should be addressed. E-mail: vfreeman{at}utmb.edu [1]: #xref-corresp-1-1